These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8319332)

  • 21. Upper limit of vulnerability predicts chronic defibrillation threshold for transvenous implantable defibrillators.
    Martin DJ; Chen PS; Hwang C; Gang ES; Mandel WJ; Peter CT; Swerdlow CD
    J Cardiovasc Electrophysiol; 1997 Mar; 8(3):241-8. PubMed ID: 9083873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Programming of implantable cardioverter-defibrillators on the basis of the upper limit of vulnerability.
    Swerdlow CD; Peter CT; Kass RM; Gang ES; Mandel WJ; Hwang C; Martin DJ; Chen PS
    Circulation; 1997 Mar; 95(6):1497-504. PubMed ID: 9118518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of successful defibrillation threshold test during CRT-D implantation.
    Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F
    Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upper limit of vulnerability determination during implantable cardioverter-defibrillator placement to minimize ventricular fibrillation inductions.
    Glikson M; Gurevitz OT; Trusty JM; Sharma V; Luria DM; Eldar M; Shen WK; Rea RF; Hammill SC; Friedman PA
    Am J Cardiol; 2004 Dec; 94(11):1445-9. PubMed ID: 15566924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated vulnerability testing identifies patients with inadequate defibrillation safety margin.
    Birgersdotter-Green U; Ruetz LL; Anand K; Monir G; Abeyratne AI; Bailey JR; Shorofsky SR; Hsia HH; Friedman PA
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1073-80. PubMed ID: 23051838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virtual electrodes and deexcitation: new insights into fibrillation induction and defibrillation.
    Efimov IR; Gray RA; Roth BJ
    J Cardiovasc Electrophysiol; 2000 Mar; 11(3):339-53. PubMed ID: 10749359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Saga of Defibrillation Testing: When Less Is More.
    Gleva MJ; Robinson M; Poole J
    Curr Cardiol Rep; 2018 May; 20(6):44. PubMed ID: 29730796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of the upper limit of vulnerability using implantable cardioverter-defibrillator electrograms.
    Swerdlow C; Shivkumar K; Zhang J
    Circulation; 2003 Jun; 107(24):3028-33. PubMed ID: 12810611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion.
    Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F
    Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Energy levels for defibrillation: what is of real clinical importance?
    Fotuhi PC; Epstein AE; Ideker RE
    Am J Cardiol; 1999 Mar; 83(5B):24D-33D. PubMed ID: 10089836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved defibrillation efficacy with an ascending ramp waveform in humans.
    Shorofsky SR; Rashba E; Havel W; Belk P; Degroot P; Swerdlow C; Gold MR
    Heart Rhythm; 2005 Apr; 2(4):388-94. PubMed ID: 15851341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic collapse, geometry, and the rapidly paced upper limit of ventricular vulnerability to fibrillation by T-wave stimulation.
    Malkin RA; Hoffmeister BK
    J Electrocardiol; 2000 Jul; 33(3):279-86. PubMed ID: 10954381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the pacing site, procainamide, and lead configuration on the relationship between the upper limit of vulnerability and the defibrillation threshold.
    Fan W; Gotoh M; Chen PS
    Pacing Clin Electrophysiol; 1995 Jun; 18(6):1279-84. PubMed ID: 7659583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrepancies between the upper limit of vulnerability and defibrillation threshold: prevalence and clinical predictors.
    Gurevitz OT; Friedman PA; Glikson M; Trusty JM; Ballman KV; Rosales AG; Hayes DL; Hammill SC; Swerdlow CD
    J Cardiovasc Electrophysiol; 2003 Jul; 14(7):728-32. PubMed ID: 12930253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Relationship Between Cardiac Vulnerability and Restitution Properties of the Ventricular Activation Recovery Interval.
    Yamashita S; Yoshida A; Fukuzawa K; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hyogo K; Imada H; Hirata K
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):768-73. PubMed ID: 25810143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of upper limit of vulnerability and defibrillation probability of success curves using a nonthoracotomy lead system.
    Souza JJ; Malkin RA; Ideker RE
    Circulation; 1995 Feb; 91(4):1247-52. PubMed ID: 7850965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Shock-induced, but not terminated ventricular tachycardia in a patient with implantable defibrillator].
    Kühlkamp V; Dörnberger V; Mermi J; Mewis C; Seipel L
    Z Kardiol; 1996 May; 85(5):306-11. PubMed ID: 8711942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The zone of vulnerability to T wave shocks in humans.
    Swerdlow CD; Martin DJ; Kass RM; Davie S; Mandel WJ; Gang ES; Chen PS
    J Cardiovasc Electrophysiol; 1997 Feb; 8(2):145-54. PubMed ID: 9147699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Low energy cardioversion with the implantable cardioversion defibrillator devices for treatment of ventricular tachycardia and ventricular fibrillation].
    Siebels J; Schneider MA; Kuck KH
    Z Kardiol; 1993 Nov; 82(11):683-91. PubMed ID: 8291289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.